Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 27 studies | 39% ± 20% | |
endothelial cell | 22 studies | 30% ± 13% | |
fibroblast | 21 studies | 35% ± 12% | |
endothelial cell of lymphatic vessel | 19 studies | 40% ± 17% | |
plasma cell | 15 studies | 32% ± 17% | |
microglial cell | 11 studies | 35% ± 12% | |
myeloid cell | 9 studies | 38% ± 16% | |
adipocyte | 9 studies | 54% ± 16% | |
dendritic cell | 9 studies | 31% ± 12% | |
glutamatergic neuron | 8 studies | 46% ± 20% | |
pericyte | 7 studies | 24% ± 8% | |
alveolar macrophage | 6 studies | 38% ± 15% | |
natural killer cell | 6 studies | 22% ± 4% | |
hepatocyte | 6 studies | 54% ± 25% | |
smooth muscle cell | 6 studies | 25% ± 10% | |
goblet cell | 6 studies | 36% ± 22% | |
plasmacytoid dendritic cell | 6 studies | 25% ± 6% | |
plasmablast | 5 studies | 53% ± 16% | |
monocyte | 5 studies | 36% ± 11% | |
type II pneumocyte | 5 studies | 23% ± 6% | |
GABAergic neuron | 5 studies | 31% ± 11% | |
epithelial cell | 5 studies | 30% ± 14% | |
pancreatic A cell | 4 studies | 46% ± 28% | |
capillary endothelial cell | 4 studies | 18% ± 3% | |
neuron | 4 studies | 37% ± 27% | |
kidney loop of Henle epithelial cell | 4 studies | 26% ± 5% | |
vein endothelial cell | 4 studies | 34% ± 17% | |
lymphocyte | 4 studies | 28% ± 9% | |
IgG plasma cell | 4 studies | 33% ± 15% | |
leukocyte | 4 studies | 23% ± 6% | |
T cell | 4 studies | 19% ± 2% | |
renal principal cell | 4 studies | 36% ± 10% | |
endothelial cell of sinusoid | 3 studies | 38% ± 17% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 20% ± 4% | |
mononuclear phagocyte | 3 studies | 36% ± 11% | |
endothelial cell of vascular tree | 3 studies | 30% ± 17% | |
cholangiocyte | 3 studies | 44% ± 20% | |
erythrocyte | 3 studies | 59% ± 29% | |
connective tissue cell | 3 studies | 25% ± 11% | |
enteroendocrine cell | 3 studies | 32% ± 6% | |
B cell | 3 studies | 29% ± 10% | |
interneuron | 3 studies | 24% ± 8% | |
astrocyte | 3 studies | 32% ± 14% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 39% ± 6% | |
renal alpha-intercalated cell | 3 studies | 29% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 10637.55 | 226 / 226 | 98% | 77.08 | 399 / 406 |
pancreas | 100% | 4373.56 | 327 / 328 | 97% | 69.29 | 173 / 178 |
kidney | 100% | 3850.04 | 89 / 89 | 96% | 58.72 | 868 / 901 |
breast | 100% | 8783.01 | 459 / 459 | 95% | 68.22 | 1067 / 1118 |
intestine | 100% | 5310.70 | 965 / 966 | 95% | 45.40 | 499 / 527 |
lung | 100% | 6762.84 | 578 / 578 | 94% | 40.69 | 1085 / 1155 |
bladder | 100% | 7651.57 | 21 / 21 | 89% | 39.16 | 451 / 504 |
stomach | 89% | 2992.77 | 319 / 359 | 95% | 56.30 | 273 / 286 |
esophagus | 91% | 4066.05 | 1308 / 1445 | 93% | 51.19 | 170 / 183 |
thymus | 100% | 6194.50 | 650 / 653 | 83% | 19.68 | 504 / 605 |
adrenal gland | 100% | 7336.29 | 258 / 258 | 76% | 29.58 | 174 / 230 |
prostate | 89% | 2724.56 | 218 / 245 | 83% | 21.40 | 416 / 502 |
uterus | 99% | 3647.45 | 168 / 170 | 71% | 24.22 | 324 / 459 |
ovary | 96% | 2912.78 | 173 / 180 | 64% | 16.28 | 275 / 430 |
skin | 95% | 4697.80 | 1726 / 1809 | 49% | 12.29 | 232 / 472 |
adipose | 100% | 12631.41 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6393.55 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 4920.52 | 241 / 241 | 0% | 0 | 0 / 0 |
brain | 37% | 906.59 | 972 / 2642 | 56% | 10.31 | 395 / 705 |
peripheral blood | 85% | 3854.31 | 787 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 42.31 | 24 / 29 |
heart | 81% | 1968.68 | 694 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 80% | 20.83 | 36 / 45 |
muscle | 43% | 773.45 | 342 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 18% | 2.59 | 14 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0045047 | Biological process | protein targeting to ER |
GO_1904382 | Biological process | mannose trimming involved in glycoprotein ERAD pathway |
GO_0036503 | Biological process | ERAD pathway |
GO_0006486 | Biological process | protein glycosylation |
GO_0000139 | Cellular component | Golgi membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005793 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0016020 | Cellular component | membrane |
GO_0004571 | Molecular function | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0015923 | Molecular function | mannosidase activity |
Gene name | MAN1A1 |
Protein name | Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA (EC 3.2.1.113) (Man(9)-alpha-mannosidase) (Man9-mannosidase) (Mannosidase alpha class 1A member 1) (Processing alpha-1,2-mannosidase IA) (Alpha-1,2-mannosidase IA) |
Synonyms | |
Description | FUNCTION: Involved in the maturation of Asn-linked oligosaccharides. Progressively trim alpha-1,2-linked mannose residues from Man(9)GlcNAc(2) to produce Man(5)GlcNAc(2). |
Accessions | P33908 ENST00000368468.4 [P33908-1] |